| Interplay between MAPK/ERK signaling pathway and MicroRNAs: A crucial mechanism regulating cancer cell metabolism and tumor progression ER Asl, M Amini, S Najafi, B Mansoori, A Mokhtarzadeh, A Mohammadi, ... Life sciences 278, 119499, 2021 | 119 | 2021 |
| Effect of root extracts of medicinal herb Glycyrrhiza glabra on HSP90 gene expression and apoptosis in the HT-29 colon cancer cell line SM Nourazarian, A Nourazarian, M Majidinia, E Roshaniasl Asian Pacific journal of cancer prevention 16 (18), 8563-8566, 2016 | 89 | 2016 |
| Antioxidants with two faces toward cancer N Dastmalchi, B Baradaran, S Latifi-Navid, R Safaralizadeh, ... Life Sciences 258, 118186, 2020 | 50 | 2020 |
| Overexpression of HMGA2 in breast cancer promotes cell proliferation, migration, invasion and stemness B Mansoori, PHG Duijf, A Mohammadi, S Najafi, E Roshani, ... Expert Opinion on Therapeutic Targets 24 (3), 255-265, 2020 | 49 | 2020 |
| MicroRNA‐124‐3p suppresses PD‐L1 expression and inhibits tumorigenesis of colorectal cancer cells via modulating STAT3 signaling E Roshani Asl, Y Rasmi, B Baradaran Journal of cellular physiology 236 (10), 7071-7087, 2021 | 37 | 2021 |
| PD-L1 silencing inhibits triple-negative breast cancer development and upregulates T-cell-induced pro-inflammatory cytokines P Lotfinejad, T Kazemi, S Safaei, M Amini, E Baghbani, SS Shotorbani, ... Biomedicine & Pharmacotherapy 138, 111436, 2021 | 34 | 2021 |
| Bile acid‐based advanced drug delivery systems, bilosomes and micelles as novel carriers for therapeutics M Nemati, A Fathi‐Azarbayjani, H Al‐Salami, E Roshani Asl, Y Rasmi Cell Biochemistry and Function 40 (6), 623-635, 2022 | 18 | 2022 |
| Mutant P53 in the formation and progression of the tumor microenvironment: friend or foe ER Asl, D Rostamzadeh, PHG Duijf, S Mafi, B Mansoori, S Barati, WC Cho, ... Life sciences 315, 121361, 2023 | 16 | 2023 |
| Interaction between DNA damage response and autophagy in colorectal cancer E Roshani-Asl, B Mansori, A Mohammadi, S Najafi, F Danesh-Pouya, ... Gene 730, 144323, 2020 | 16 | 2020 |
| COVID-19 infection: concise review based on the immunological perspective P Lotfinejad, Z Asadzadeh, S Najjary, MH Somi, K Hajiasgharzadeh, ... Immunological Investigations 51 (2), 246-265, 2022 | 12 | 2022 |
| Molecular mechanisms of breast cancer chemoresistance by immune checkpoints N Dastmalchi, R Safaralizadeh, A Baghbanzadeh, K Hajiasgharzadeh, ... Life Sciences 263, 118604, 2020 | 11 | 2020 |
| Role of neurotransmitters and neuropeptides in breast cancer metastasis FD Pouya, Y Rasmi, ER Asl Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology 14 …, 2020 | 11 | 2020 |
| The synergy between miR-486–5p and tamoxifen causes profound cell death of tamoxifen-resistant breast cancer cells B Mansoori, S Najafi, A Mohammadi, H AsadollahSeraj, P Savadi, ... Biomedicine & Pharmacotherapy 141, 111925, 2021 | 8 | 2021 |
| Crosstalk between miRNAs and signaling pathways involved in pancreatic cancer and pancreatic ductal adenocarcinoma Z Lotfi, S Najjary, F Lotfi, M Amini, A Baghbanzadeh, DJ Rashid, ER Asl, ... European Journal Of Pharmacology 901, 174006, 2021 | 8 | 2021 |
| Curcumin, an inhibitor of PAK1, potential treatment for COVID-19 M Nemati, ER Asl, FD Pouya, Y Rasmi Journal of Infectiology and Epidemiology 3 (2), 2020 | 8 | 2020 |
| Relation between Immune cell response and stemness genes expression in breast cancer; A new approach in NANOG gene and Let7-a expression in breast cancer cell lines Z Aliyari-Serej, A Ebrahimi, T Kazemi, S Najafi, E Roshani, ... Immunopathologia Persa 6 (2), e21-e21, 2020 | 6 | 2020 |
| MicroRNA targeting: A novel therapeutic intervention for ovarian cancer ER Asl, S Sarabandi, B Shademan, K Dalvandi, A Nourazarian Biochemistry and Biophysics Reports 35, 101519, 2023 | 3 | 2023 |
| The combined therapy of miR-383-5p restoration and paclitaxel for treating MDA-MB-231 breast cancer N Dastmalchi, S Azarbarzin, R Safaralizadeh, SMB Khojasteh, ... Medical Oncology 39, 1-11, 2022 | 3 | 2022 |
| Increased levels of angiogenic factors in microvascular angina ER Asl, Y Rasmi, MH Khadem-Ansari, MH Seyed-Mohammadzad, ... Medicine and Pharmacy Reports 92 (1), 31, 2019 | 3 | 2019 |
| GW27-e0621 Angiopoietin-2 as a biomarker for patients with Cardiac Syndrome X Y Rasmi, E Roshani-Asl, MH KhademAnsari, MH SeyedMohammadza, ... Journal of the American College of Cardiology 68 (16S), C24-C24, 2016 | 3 | 2016 |
Yousef RasmiDepartment of Biochemistry, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran在 umsu.ac.ir 的电子邮件经过验证
